What is Phreesia?
Founded in 2005 and headquartered in Wilmington, Delaware, Phreesia operates at the critical intersection of patient engagement and administrative efficiency. The company provides a comprehensive software platform designed to streamline the intake process for medical groups, health systems, and payers. By digitizing patient registration, payments, and clinical data collection, Phreesia enables healthcare providers to optimize operational workflows and improve the overall patient experience. Its market position is defined by its ability to integrate seamlessly into existing electronic health record systems, making it an essential tool for modernizing healthcare delivery and achieving strategic financial objectives.
How much funding has Phreesia raised?
Phreesia has raised a total of $653.6M across 9 funding rounds:
Series B
$10.3M
Series C
$11.6M
Series D
$20M
Corporate Investment
$30M
Stock Offering
$140.6M
Debt
$5M
Stock Offering
$174.4M
Stock Offering
$258.8M
Series B (2007): $10.3M led by Polaris Partners, Village Ventures, HLM Venture Partners, and Long River Ventures
Series C (2009): $11.6M supported by HLM Venture Partners, BlueCross BlueShield Venture Partners, Long River Ventures, Sandbox Industries, and Polaris Partners
Series D (2010): $20M featuring Vantage Point Ventures, Long River Ventures, HLM Venture Partners, Ascension Ventures, Sandbox Industries, Polaris Partners, and BlueCross BlueShield Venture Partners
Corporate Investment (2014): $30M backed by LLR
Stock Issuance/Offering (2019): $140.6M with participation from Undisclosed
Debt (2020): $5M led by PPP
Stock Issuance/Offering (2020): $174.4M, investors not publicly disclosed
Stock Issuance/Offering (2021): $258.8M, investors not publicly disclosed
Key Investors in Phreesia
Polaris Partners
Polaris Partners is a venture capital firm that specializes in backing transformational companies in the biotech and healthcare sectors. Their team of entrepreneurs and scientists provides deep operational expertise to foster innovation.
HLM Venture Partners
A specialized healthcare investment firm that partners with innovative founders to build enduring companies in healthcare technology and services, offering strategic guidance and growth capital.
BlueCross BlueShield Venture Partners
This firm manages capital across funds to invest in emerging companies of strategic relevance to Blue Cross and Blue Shield plans, focusing on the intersection of entrepreneurial thinking and large corporate enterprises.
What's next for Phreesia?
Looking ahead, Phreesia is well-positioned to leverage its significant capital reserves to expand its footprint in the digital health ecosystem. The company's history of securing major enterprise-level funding suggests a focus on scaling its product suite and potentially pursuing inorganic growth opportunities. As the healthcare industry continues to prioritize interoperability and patient-centric digital tools, Phreesia's strategic roadmap likely involves deepening its integration with large-scale health systems and enhancing its data analytics capabilities to provide greater value to payers and providers alike. The firm remains a key entity to watch as it continues to refine its technology stack to meet the evolving demands of the healthcare sector.
See full Phreesia company page
